A 61-year-old woman with bilateral anorectal ulceration was investigated and treated by various specialists for nearly one year before an anocutaneous ergotism, following regular abuse of migraine suppositories, could be diagnosed. The case demonstrates the considerable diagnostic difficulties in this unusual manifestation of medicinal ergotamine intoxication.
Case report In July 1982 the patient presented with yellowish, symmetrical, anal ulcers each about 4.0 cm in diameter ( Figure 1A) . The lesions were so strikingly painful, spontaneously and at the slightest touch, that rectoscopy had to be performed under spinal anaesthesia. They extended from the dentate line to the mucosa of an otherwise normal rectum. The biopsies yielded nothing but an unspecific chronic ulcerating inflammation.
The patient gave a history of Parks' haemorrhoidectomy in October 1981 with uneventful wound healing. At the beginning of December 1981 she experienced increasingly burning pain at the sites of operation, which were quite inconspicuous on several examinations at that time. Four weeks later two extremely painful ulcers developed there, and these were treated by her family doctor for four months. In April and May 1982 she received clinical treatment in a dermatological and a medical hospital without resolution of the ulcers. Syphilis, tuberculosis, fungal infection, allergy and Crohn's disease were all excluded; the last had been suspected due to concomitant, recurrent A's~F igure 1. Symmetrical ulcers (A) due to ergotamine suppositories, on admission. After discontinuation of the suppositories, the ulcers showed marked granulation at 2 weeks (B), and by 10 weeks had healed (c) Her history gave no clues, and she repeatedly denied taking any drugs apart from occasional tablets for headache.
After a sigmoid colostomy without any improvement and subsequent plastic coverage by rotation flaps in August 1982, she developed multiple small ulcers in both flaps which became confluent after a fortnight, so that her condition was considerably worsened.
Self-inflicted injury was by then suspected but there was no psychiatric evidence for it. Finally, in October 1982, the remains of a suppository were found by chance in one of the dressings. Only after the chemical analysis had revealed a common type of migraine suppository (AvamigranQ), containing 1.5 mg of ergotamine-tartrate, did the patient admit to daily abuse of at least one or two of these sUppositories. She had taken them for nearly one year, initially because of her migraine but increasingly for her intolerable perianal pain. The suppositories were discontinued immediately and 2 weeks later the ulcers showed healthy granulation ( Figure 1B ). After 4 weeks the burning pain, as well as the occasional abdominal pain, subsided and after 10 weeks the ulcers had healed completely without any further measures ( Figure lc ). After the remaining anal stenosis had been treated by regular dilatation, a severe impairment of continence became apparent and the' patient elected to have a permanent colostomy.
Even though the diagnosis had not been made histologically, scrutiny of the tissue excised at the time of plastic coverage revealed a few small arteries in the subcutaneous fatty tissue at some distance below the ulcers which showed what seem to be fairly characteristic changes ( Figure 2 ) according to the sparse and partly contradictory reports from the literature -4.
Our impression that the condition was likely to be more common than might be concluded from the few cases so far published was confirmed by 3 further patients seen subsequently. The first was a 27-year-old woman, suffering from extensive perianal ulceration, burning anal pain and colicky abdominal pain for one year, who had been applying excessive amounts of ergot suppositories for 8 years. The second woman, aged 45 years, who presented with burning perianal pain and multiple small ulcers of the anal canal, reported a history of 20 years of migraine and had taken ergot suppositories for 6 years. The third patient was a 51-year-old woman presenting with chronic anal lesions and burning anal pain occurring several months after an uneventful haemorrhoidectomy; she also reported longstanding abuse of ergot suppositories. In all patients the lesions healed completely and all complaints subsided within 6-10 weeks after discontinuing the ergot suppositories.
Discussion
Anorectal ulcers due to the topical and possibly additional systemic effects of ergotamine are extremely rare. Apart from our 4 patients, we know ofonly 2 further cases in the literature5'6. This is surprising because generalized side effects like vomiting, nausea and transient leg pain do occur in some 10% of patients taking ergot preparations orally or rectally, while ergot intoxication may be expected in 0.01%°'/. Nevertheless, the features of anorectal ergotism are so clearcut that the diagnosis ought to be made clinically if the condition is taken into account at all.
All the patients described so far were females, as were the vast majority of patients, suffering from ergotism at other sites1. It is not well understood why this should be so, because more than one-third of the migraine patients were males.
All reported patients with ergotamine-induced anorectal ulcers took doses of ergotamine far beyond the recommended limits of 10 mg/week (suppositories contain 1-4 mg ergotamine tartrate each), but they did not generally admit this9'10. They used ergotamine suppositories (which are intended only for the treatment of acute attacks and for very short periods8) on a regular basis for months and years. This seems to be due to the fact that patients on ergot preparations are very prone to becoming dependent on the drug'0 and may even develop genuine addiction, particularly as a result of Nevertheless, there is no reliable correlation between the doses of ergotamine, the plasma levels and the pharmacological or toxic effects9"'. Ergot intoxication has been described after a single normal dose, and some patients do seem to be unduly sensitive to ergotamine'", which may be one of the reasons for the occurrence of rectal ulcers.
A second striking fact is that all cases ofergotamine ulcers have been caused by suppositories. This might be due to the local action of ergotamine, but also to the fact that with suppositories the plasma levels of ergotamine are 10 times higher than with oral administration due to the avoidance of a firstpass effect'2"3.
The third factor might be a local predisposition by previous haemorrhoidectomy or pre-existing eczema, as was the case in 2 of our patients and one case reported in the literature5.
Severe burning perianal pain is the most prominent symptom of anorectal ergotism and will precede the development of ulcers by approximately 4 weeks. Concomitant colicky abdominal paina symptom we observed twicemay well give rise to confusion with Crohn's disease. The importance ofboth symptoms is confirmed by the report of Gabbai et al.'4, who described several patients with burning pain at the anus and subhepatic colicky abdominal pain out of 150 cases seen during the last European epidemic of ergot poisoning in southern France, as well as by the description'5 of subtotal mesenteric infarction by massive ergotamine overdose in young patients.
Biopsies from the ulcers themselves will not, as a rule, support the diagnosisas we experienced in 2 cases -because only arteries at some distance from the ulceration, which are not subject to direct inflammatory influences of the ulcer, show typical changes'. Apart from intravenous nitroprusside, nitroglycerine and calcium antagonists, which have been effective in a few cases82"6, immediate withdrawal of ergotamine medication is the causal therapy for any manifestation of medicinal ergotism. If this leads to disappearance of any pain within 4 weeks and complete healing of longstanding anorectal ulcers within 10 weeks, the diagnosis of anorectal ergotism can be assumed on clinical grounds.
The prognosis seems to depend on the time of diagnosis and the severity of ergotamine abuse. In our first case, with a particularly longstanding and excessive overdosage, severe fibrosis and incontinence developed. Hochter et al.6 described a case of 15 years' abuse with consequent rectovaginal fistula and circular fibrosis. The latter may be the result ofa further specific action of ergotamine beyond chronic inflammation, because various forms of fibrosis such as retroperitoneal, pleuropulmonary and pericardial fibrosis have been reported following longstanding overdosage of ergotamine3'17. Apart from these severe cases, complete restitution can be expected in most cases of anorectal ulcers due to migraine suppositories. Hypoglycaemia due to quinine therapy occurs in the treatment of malaria' and an asymptomatic case has been reported following treatment for muscle cramp2. We report a case of severe persistent hypoglycaemia in a patient with terminal renal failure who had been treated for muscle cramp with quinine. The findings accord with the hypothesis that quinine causes inappropriate insulin release by the pancreatic beta-cell.
Case report
A 72-year-old woman was admitted in hypoglycaemic coma (blood glucose < 1.0 mmol/l) which responded immediately to infusion of 50 ml 50% dextrose. Seven years previously she had undergone left mastectomy for poorly differentiated adenocarcinoma of the breast and three months before had developed a recurrence with subcutaneous metastases. For three days she had suffered anorexia and severe muscle cramps and had become anuric. Her therapy for several months had comprised ibuprofen 200 mg three times daily, with lorazepam 1 mg and quinine sulphate 300 mg taken at night. There was no past history or family history ofdiabetes mellitus. Neither the patient nor any family member had been treated with or had access to insulin or oral hypoglycaemic agents. On examination she had a large pelvic mass. Blood urea was 47.4 mmol/l and creatinine 1730 mmol/l, and a diagnosis of renal failure due to ureteric obstruction was made. Details of other biochemical measurements are given in Table 1 .
For the seven days until she died continuous intravenous infusion of dextrose was required to prevent recurrent hypoglycaemia. At post-mortem widespread metastatic breast cancer with bilateral ureteric obstruction was confirmed. The adrenals were partially replaced by metastases but the pancreas appeared normal. Immunohistology using guinea-pig antibodies to human insulin and glucagon (Dakopatts, Santa Barbara, Califomia, USA) demonstrated the presence and normal distribution of these hormones in the pancreas. In contrast, neither hormone was identified in the breast carcinoma. Hepatic glycogen stores were exhausted.
Discussion
Spontaneous hypoglycaemia is an uncommon condition. It has been reported in patients with endstage renal failure but the causal mechanism is 0141-0768/86/ 070426-03/$02.00/0 @ 1986 The Royal Society of Medicine
